The science behind longer-term dosing interval for GLP-1 and NuSH peptides Achieving a monthly or longer-term dosing interval for GLP-1 peptide involves a number of factors and corresponding challenges below: 1) Longer half-life: Half-life is a measure of drug clearance rate which is essential to increasing dose interval
Cumulative weight loss often reaches 5-10% of starting body weight by the end of month three
Cell Chem Biol 27:409419 Xie M, Sun X, Li P, Shen X, Fang Y (2021) Selenium in cereals: insight into species of the element from total amount
When we don't get enough iron, we may experience: Reduced capacity to exercise and skeletal muscle atrophy, even before iron deficiency anemia (IDA) develops Over time, IDA, resulting in abnormal red blood cell formation and symptoms such as fatigue, weakness, difficulty concentrating, impaired cognitive and immune function, and poor body temperature regulation IDA has also been linked to impaired glucose metabolism---potentially due to poor conversion of proinsulin to active insulin in the body
